entertainment -WSS

entertainment

author：leisure time 2025-10-02 15:44:17 - browse：9

Silhouetted hands passing money. -- health business coverage from STAT — Adobe

The federal government has started penalizing Medicare Advantage insurers that have one common, glaring problem: Faulty technology systems are leading to people paying more for care and coverage than they should be.

The Centers for Medicare and Medicaid Services fined three different Medicare Advantage plans this month, each one getting dinged differently for the way they overcharged their members. The fines are minuscule for the insurance companies — roughly equivalent to some pennies under a couch cushion — but they could serve as warnings for companies to clean up their compliance and IT infrastructure before regulators knock on their doors again.

“Just the knowledge that CMS will be back one day and that you better have this fixed, I think, does have a sentinel effect,” said Philip Legendy, an attorney at Ballard Spahr who represents Medicare Advantage plans. “And if you’re doing it over and over, it could be viewed as intentional.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

WSS

Roche drug slashes death risk in early

Medicare proceeds with plan to claw back hospital funds

STAT Summit: Ending the crisis of Black deaths in the U.S.

Humans aren't the only ones with an imagination. Rats have it too

All of Us, NIH's precision medicine initiative, gets a big boost

DeepMind touts AlphaFold's new skills as protein folding AI models face off

focus

entertainment

explore

How one medical school became remarkably diverse

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Novavax promises a turnaround & Lilly roils the obesity market

Explaining an after

Supreme Court strikes down use of affirmative action

Travis Kelce and the trap of celebrity vaccine endorsements

Anesthesiologist group: stop taking Ozempic before surgery

Merck, Daiichi strike cancer drug pact worth up to $22 billion

BioMarin wins approval for gene therapy to treat hemophilia A

Kidney transplant patients stopped immunosuppressants in trial

focus

STAT Summit: How researchers deal with rejection

Infant mortality in U.S. rose last year for first time in decades: CDC

DeepMind touts AlphaFold's new skills as protein folding AI models face off

After Sarepta trial failure, Duchenne families brace for more debate

Readout LOUD podcast: Live from the 2023 STAT Summit

STAT Summit: How researchers deal with rejection

hotspot

explore

hotspot

hotspot